耐久医療機器（DME）市場規模、成長と動向分析レポート 2026-2033年

世界の耐久医療機器（DME）市場規模は、2025年には2,460億2,000万米ドルと評価され、2033年には3,798億2,000万米ドルに成長し、2026年から2033年にかけて年平均成長率（CAGR）5.70%に達するとGrand View Researchでは予測しています。この業界は、慢性疾患の蔓延、高齢化、長期介護および在宅介護への需要増加によって牽引されています。

主要市場動向と洞察

• 北米は、2025年に34.70%という最大の収益シェアを獲得し、耐久医療機器（DME）市場を牽引しました。
• 2025年、米国の耐久医療機器（DME）市場は北米で最大の市場収益シェアを占めた。
• 製品別に見ると、2025年にはモニタリングおよび治療機器分野が最大の収益シェアを獲得し、市場を牽引した。
• 用途別に見ると、2025年には病院分野が最大の収益シェアを獲得し、市場を牽引した。

スマートで接続された軽量医療機器などの技術進歩により、患者の利便性と治療効率がさらに向上しています。さらに、医療に対する意識の高まりと支援的な償還政策により、市場での普及が加速しています。世界保健機関（WHO）によると、慢性閉塞性肺疾患（COPD）と喘息は最も一般的な慢性呼吸器疾患（CRD）であり、CRD関連の死亡の約80％はCOPDによるものです。世界的な人口高齢化と複数の健康上の課題により、COPDの症例は2050年までに世界中で23％増加すると予測されており、女性や低・中所得国の人々に不均衡な影響を与えています。

糖尿病、心血管疾患、呼吸器疾患、運動機能障害などの慢性疾患の罹患率の上昇は、DME（耐久医療機器）市場の主要な成長要因となっています。これらの疾患は、多くの場合、長期的な管理、継続的なモニタリング、およびサポートケアを必要とするため、血糖値測定器、酸素濃縮器、移動補助具、治療機器などの需要が高まっています。慢性疾患の世界的な罹患率の上昇に伴い、患者は症状の管理、生活の質の向上、入院回数の削減のためにDMEに頼るようになっています。このような継続的なケアソリューションへのニーズの高まりが、DME市場の成長を後押しし続けています。

耐久医療機器主要企業に関する洞察

耐久医療機器（DME）市場は、大手ヘルスケア企業と、幅広い在宅介護・移動機器を提供する専門メーカーによって支配されています。市場シェアは主に、強力な流通網、製品の信頼性、そして償還制度への適合性によって左右されます。一方、小規模企業は、ターゲットを絞った革新的な製品・サービスによって支持を得ています。

本レポートは、世界、地域、国レベルでの収益成長を予測し、2021年から2033年までの各サブセグメントにおける最新の業界動向を分析しています。本調査において、Grand View Researchは、世界の耐久医療機器（DME）市場レポートを製品、最終用途、地域に基づいてセグメント化しました。

Durable Medical Equipment Market Summary

The global durable medical equipment market size was valued at USD 246.02 billion in 2025 and is projected to reach USD 379.82 billion by 2033, growing at a CAGR of 5.70% from 2026 to 2033. The industry is driven by the rising prevalence of chronic diseases, an aging population, and increasing demand for long-term and home-based care.

Technological advancements such as smart, connected, and lightweight medical devices further enhance patient convenience and treatment efficiency. Furthermore, growing healthcare awareness and supportive reimbursement policies are accelerating market adoption. According to the World Health Organization (WHO), chronic obstructive pulmonary disease (COPD) and asthma are the most common chronic respiratory diseases (CRDs), with COPD accounting for nearly 80% of CRD-related deaths. With an aging global population and multiple health challenges, COPD cases are projected to rise by 23% worldwide by 2050, disproportionately affecting women and individuals in low- and middle-income countries.

The growing prevalence of chronic diseases such as diabetes, cardiovascular disorders, respiratory conditions, and mobility-limiting illnesses is a major driver of the DME market. These conditions often require long-term management, continuous monitoring, and supportive care, increasing demand for equipment such as glucose monitors, oxygen concentrators, mobility aids, and therapeutic devices. As the global prevalence of chronic diseases rises, patients depend on DME to manage symptoms, improve quality of life, and reduce hospital visits. This sustained need for ongoing care solutions continues to fuel growth in the DME market.

Cardiovascular disease cases are increasing due to this rising demand for long-term monitoring and therapeutic devices, such as blood pressure monitors, oxygen concentrators, and mobility aids. The need for continuous care, rehabilitation, and home-based management of CVD patients supports DME adoption.

Market Concentration & Characteristics

The industry is experiencing significant innovation, driven by advances in technology and patient-centered design. Companies are integrating smart features, IoT connectivity, and AI-driven monitoring into wheelchairs, beds, and home care devices, enhancing functionality and patient safety. Lightweight materials, modular designs, and customizable solutions further improve usability and accessibility. This continuous innovation meets evolving healthcare needs and opens new opportunities for growth in home and clinical care settings. For instance, in January 2026, Graham-Field, a leading provider of healthcare equipment and resident-centered solutions, announced the launch of the AmeriLux Extended Care Bed, a breakthrough in safe patient handling, comfort, and modern caregiving efficiency. Designed to meet the evolving needs of senior living communities, rehabilitation centers, and long-term care facilities, the AmeriLux sets a new standard for resident care.

“We designed the AmeriLux with one mission: to create a bed that not only improves safety and comfort for residents but meaningfully enhances the workflow of caregivers. This bed represents the next evolution of thoughtful, evidence-based long-term care design.” said Peter Loope, President.

Similarly, in August 2025, Sunrise Medical introduced the Empulse M90 with a groundbreaking wheel add‑on that redefines assisted mobility by blending sleek design, superior functionality, and high performance. Its integrated, lightweight build delivers discreet power assist without the bulk, wires, or external components commonly found in similar devices.

The DME industry has witnessed a significant number of mergers and acquisitions, driven by the need to expand portfolios, integrate technology, and expand geographic reach. Leading players are acquiring niche companies to gain access to innovative products, advanced technologies, and established distribution networks. For instance, in June 2025, Invacare America, a global provider of home and long-term care medical products, announced a strategic partnership between its Freedom Designs and Matrx, by Motion Concepts, divisions. This collaboration brings together Freedom Designs’ custom manual wheelchair expertise with Matrx’s advanced seating technology to deliver integrated, on-chair wheelchair and seating solutions that enhance personalized comfort and support for customers.

“When crafting wheelchairs, the goal is not only to provide solutions to people with mobility challenges – it is to enhance their lives. Through this partnership, we can more effectively get products to customers that help empower individuals to move freely and comfortably in their daily lives.” said Gavriela Guerrero, managing director of Freedom Designs.

“This collaboration reinforces our commitment to delivering advanced, comprehensive mobility solutions that place users’ needs first. By increasing access to our innovative products, we can reach and support even more people who could benefit from these products.” said Judy Rowley, vice president of Matrx.

Rowley added, “We invite clinicians, providers, and stakeholders to explore these new integrated offerings and join us in maximizing patient outcomes through better mobility and seating care.”

The industry is significantly influenced by regulations that ensure the safety, quality, and efficacy of medical devices. Stringent government standards, certification requirements, and compliance protocols can increase product development time and costs for manufacturers. While these regulations protect patients and build trust in the market, they also pose challenges for new entrants and smaller companies trying to innovate. Regulatory frameworks shape market dynamics by balancing patient safety with industry growth.

The industry faces competition from various product substitutes, including non-device therapies, outpatient care, and over-the-counter medical aids. For example, physical therapy, home exercise programs, or rental equipment can replace certain mobility or rehabilitation devices. These substitutes can limit demand for high-cost or specialized DME products, encouraging manufacturers to innovate, differentiate, and focus on value-added features to maintain market share.

The Durable Medical Equipment (DME) industry exhibits high end-use concentration, with significant demand coming from hospitals, rehabilitation centers, long-term care facilities, and home healthcare settings. Hospitals and clinics drive the adoption of advanced monitoring and therapeutic devices, while home healthcare relies on mobility aids and patient care equipment. This concentration highlights the critical role of institutional buyers in shaping market trends, purchasing decisions, and product development strategies.

Product Insights

The monitoring and therapeutic devices segment dominated the DME industry in 2025, driven by the growing prevalence of chronic diseases and the increasing demand for continuous patient care. Devices such as blood sugar monitors, continuous passive motion (CPM), infusion pumps, and therapeutic aids are widely used in hospitals, rehabilitation centers, and home healthcare settings. Their essential role in improving patient outcomes, ensuring safety, and enhancing clinical efficiency makes this segment the largest contributor to market revenue. For instance, in April 2025, DexCom, Inc., a global provider of glucose biosensing, announced that the FDA cleared the Dexcom G7 15-Day Continuous Glucose Monitoring System for adults aged 18 and older with diabetes in the United States. Featuring an overall MARD of 8.0%, the Dexcom G7 15-Day builds on the proven performance of Dexcom CGM, which has been clinically shown to lower A1C, reduce hyper- and hypoglycemia, and increase time in range.

“The approval of Dexcom G7 15 Day marks another major innovation for Dexcom. By listening to the needs of our users, we’re proud to offer the longest-lasting, wearable and most accurate CGM, giving people the knowledge to better control their diabetes with our best-in-class technology. This milestone sets a new standard in CGM and is a testament to our continued leadership in glucose biosensing. We look forward to bringing it to market in the second half of this year, but in the meantime, we encourage our users to upgrade to our current G7 system to gain the benefits of the most connected CGM brand in the world.” said Jake Leach, executive vice president and chief operating officer at Dexcom.

“Dexcom G7 15 Day makes managing diabetes even easier with its extended wear and greater accuracy. Data recently released during the 18th international Advanced Technologies and Treatments for Diabetes conference in Amsterdam supports that G7 15 Day is the most accurate CGM for adults.” said Satish Garg, MD, from Barbara David Center for Diabetes at the University of Colorado School of Medicine.

The bathroom safety devices and medical furniture segment is expected to grow the fastest in the DME market during the forecast period, driven by the rising aging population and increasing focus on home safety and fall prevention. Growing awareness of injury prevention, coupled with demand for ergonomic, supportive, and accessible furniture, is fueling adoption. Innovations in design, comfort, and portability are further accelerating growth in this segment.

Increasing awareness around intimate hygiene, rising adoption of bidet technology, and the shift toward premium smart home sanitation products are expected to drive strong demand for such differentiated offerings in the coming years. For instance, in January 2026, Kohler introduced the KOHLER PureWash E860 Dual-Wand Elongated Bidet Toilet Seat – a first-to-market solution featuring both front and rear bidet wands. The product is specifically designed to support women’s health and hygiene needs across different life stages, including menstruation, pregnancy, postpartum recovery, and menopause. The launch reflects the growing demand for advanced, hygiene-focused smart bathroom solutions, particularly those tailored to women’s wellness.

“Wellness is at the heart of what we do, and this innovation addresses a gap in the home wellness market that has been neglected for a long time,” said Emma Felty, Senior Product Analyst – Smart Toilets and Bidet Seats. “We are proud to offer this first to market solution that is focused on the unique needs of women of all ages, and look forward to continuing to innovate, by expanding this dual-wand experience to additional bidet products moving forward.”

End Use Insights

The hospitals segment dominated the DME market in 2025, driven by the growing need for advanced patient care, surgical support, and critical care equipment. Hospitals continue to invest heavily in mobility aids, monitoring devices, and therapeutic equipment to improve patient outcomes and operational efficiency. Their large-scale procurement and preference for high-quality, technologically advanced devices make this segment a key revenue driver in the market.

The home healthcare segment is expected to grow the fastest in the DME market during the forecast period, driven by rising patient preference for home care and an aging population. Demand for mobility aids, home monitoring systems, and portable therapeutic devices is driving this growth. In addition, advancements in lightweight, user-friendly, and connected devices are making home care more accessible and efficient, increasing market adoption.

Key Durable Medical Equipment Company Insights

The durable medical equipment market is dominated by a combination of major healthcare corporations and specialized manufacturers that offer a wide range of home care and mobility equipment. Market share is largely driven by strong distribution capabilities, product reliability, and alignment with reimbursement policies, while smaller players gain support through targeted and innovative offerings.

Recent Developments

• In January 2026, Graham-Field, a leading provider of healthcare equipment and resident-centered solutions, launched the AmeriLux Extended Care Bed, a breakthrough in safe patient handling, comfort, and caregiving efficiency. Designed to meet the evolving needs of senior living communities, rehabilitation centers, and long-term care facilities, the AmeriLux sets a new standard for resident care.

“We designed the AmeriLux with one mission: to create a bed that not only improves safety and comfort for residents, but meaningfully enhances the workflow of caregivers, This bed represents the next evolution of thoughtful, evidence-based long-term care design,” said Peter Loope, President.

• In January 2026, All Star Wheelchairs released its annual report analyzing trends in electric wheelchair use across the U.S. The 2025 report explores changing consumer preferences, demographic shifts, accessibility challenges, and the role of technology in advancing mobility solutions for people with disabilities and age-related mobility limitations.
• In December 2025, Baxter International Inc., a provider of infusion therapies and technologies, announced collaborative data with The University of Texas Medical Branch (UTMB Health) showing that integrating smart infusion pumps with hospital electronic medical records (EMRs) positively impacts patient safety, clinicians’ bedside productivity, and programming compliance. The analysis, covering over one million infusions using Baxter’s Spectrum IQ large-volume infusion pumps (LVPs) at UTMB, was presented at the American Society of Health-System Pharmacists (ASHP) 2025 Midyear Clinical Meeting, held from December 7-10, 2025.

“Health systems face mounting challenges, from resource shortages to staff fatigue, yet remain committed to delivering the highest standards of care,” said Jay Ehrlich, MD, vice president of global patient safety and clinical research at Baxter. “Baxter is proud to provide technologies that help address these priorities and foster ongoing quality improvement initiatives to help advance patient safety and address cognitive overload for clinicians. The findings presented at ASHP, developed in collaboration with the University of Texas Medical Branch, reinforce the potential broad impact of, and opportunities associated with, smart infusion pump EMR integration.”

“Integrating smart infusion pumps with our EMR is more than a technology upgrade-it’s a commitment to safer, more efficient care at the bedside. This collaboration helps our clinicians spend less time troubleshooting and more time focusing on patients,” said Juanita Norton, PhD, MBA, MSN, CPHQ, RN-BC, CPN, CLSSBB, program manager, quality improvement, The University of Texas Medical Branch.

• In November 2025, Abbott initiated a medical device correction in the United States for certain FreeStyle Libre 3 and FreeStyle Libre 3 Plus sensors after internal testing revealed that some sensors might produce inaccurate low-glucose readings.
• In August 2025, Sunrise Medical introduced the Empulse M90 with a groundbreaking wheel add‑on that redefines assisted mobility by blending sleek design, superior functionality, and high performance. Its integrated, lightweight build delivers discreet power assist without the bulk, wires, or external components commonly found in similar devices.
• In August 2025, Sunrise Medical, a global provider of advanced assistive mobility solutions, launched the Voice Activation feature for its Switch-It CTRL+5 power seating control module, becoming the first company in the industry to offer a voice-activated power seating system.
• In June 2025, Invacare America, a global provider of home and long-term care medical products, announced a strategic partnership between its Freedom Designs and Matrx, by Motion Concepts, divisions. This collaboration brings together Freedom Designs’ custom manual wheelchair expertise with Matrx’s advanced seating technology to deliver integrated, on-chair wheelchair and seating solutions that enhance personalized comfort and support for customers.
• In April 2025, DexCom, Inc., a global provider of glucose biosensing, announced that the FDA cleared the Dexcom G7 15-Day Continuous Glucose Monitoring System for adults aged 18 and older with diabetes in the U.S. Featuring an overall MARD of 8.0%, the Dexcom G7 15-Day builds on the proven performance of Dexcom CGM, which has been clinically shown to lower A1C, reduce hyper- and hypoglycemia, and increase time in range.

“The approval of Dexcom G7 15 Day marks another major innovation for Dexcom. By listening to the needs of our users, we’re proud to offer the longest-lasting, wearable and most accurate CGM, giving people the knowledge to better control their diabetes with our best-in-class technology. This milestone sets a new standard in CGM and is a testament to our continued leadership in glucose biosensing. We look forward to bringing it to market in the second half of this year, but in the meantime, we encourage our users to upgrade to our current G7 system to gain the benefits of the most connected CGM brand in the world.” said Jake Leach, executive vice president and chief operating officer at Dexcom.

• In March 2025, Airchair, a wheelchair manufacturer, launched the Airchair II, specifically designed to comply with US DOT Regulation 14 CFR Part 382.65. Its innovative design addresses aircraft space constraints while meeting the needs of passengers with reduced mobility. Airlines and cabin crew benefit from a lightweight (6.8 kg / 15 lb) aisle chair that is easy to stow, deploy, and maneuver throughout the aircraft.
• In March 2025, Graham-Field introduced the Hausted 5B800ST All-Purpose Bariatric Electric Stretcher, engineered to meet patient management needs while offering the versatility to support every phase of care, from pre-op treatment to post-op recovery.

“As the number of bariatric patients increases, healthcare facilities need proper equipment to safely care for these patients while ensuring staff safety. Our new All Purpose Bariatric stretcher not only provides patient comfort but also enhances efficiency with features like the optional Navigator Power Drive System- an improvement that every hospital seeks,” said Cynthia Counts, Chief Product Officer for Graham-Field.

• In October 2024, Permobil is launching two new aluminum ultra-lightweight manual wheelchairs, the TiLite X and TiLite Z, offering best-in-class performance, over 1 billion configuration options, and industry-leading 5-day lead times.

“We have taken everything you know and love about our TiLite products and made them even better. With a tremendous focus on end user and customer insights, we have improved functionality, simplicity, weight, weight capacity and lead times – all while keeping our industry-best configurability and durability. I couldn’t be prouder of what our team has accomplished,” said Chuck Witkowski, president of Permobil Americas.

“Our goal with the TiLite X and Z was to deliver the quality, performance, durability, and customizability of TiLite chairs to as many people as possible. We are proud to say we have delivered on that and are excited to expand TiLite to more users.” said Cody Verrett, VP and general manager of Permobil Americas.

• In June 2024, Invacare employees from 20 countries participated in a global fundraising campaign, raising more than USD 28,000. With each wheelchair costing USD 96, the funds raised will provide 294 wheelchairs through Free Wheelchair Mission to people with disabilities in under-resourced countries, helping transform lives by improving mobility, independence, and quality of life.

“The Move for Mobility global fundraiser was a very successful effort of the Invacare team. This campaign illustrates our company’s commitment to accessibility and inclusion across communities worldwide.” said Geoff Purtill, our Invacare’s President and CEO, spent the last week in the Dominican Republic distributing wheelchairs with Free Wheelchair Mission.

• In April 2024, GF Health Products, Inc. announced the acquisition of substantially all assets of Transfer Master Products, Inc. (“TMP”), a company with over 30 years of experience designing and manufacturing high-quality hi-low adjustable beds for home and healthcare settings.

Durable Medical Equipment Market Report Scope

Global Durable Medical Equipment Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis on the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global durable medical equipment market report on the basis of product, end use, and region:

• Product Outlook (Revenue, USD Million; 2021 – 2033)
  • Personal Mobility Devices
    • Wheelchairs
    • Scooters
    • Walker and Rollators
    • Canes and Crutches
    • Door Openers
    • Other Devices
  • Bathroom Safety Devices and Medical Furniture
    • Commodes and Toilets
    • Mattress & Bedding Devices
  • Monitoring and Therapeutic Devices
    • Blood Sugar Monitors
    • Continuous Passive Motion (CPM)
    • Infusion Pumps
    • Nebulizers
    • Oxygen Equipment
    • Continuous Positive Airway Pressure (CPAP)
    • Suction Pumps
    • Traction Equipment
    • Others Equipment
• End Use Outlook (Revenue, USD Million; 2021 – 2033)
  • Hospitals
  • Nursing Homes
  • Home Healthcare
  • Other End-user
• Regional Outlook (Revenue, USD Million; 2021 – 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.1.1. Product
1.1.2. End Use
1.1.3. Regional scope
1.1.4. Estimates and forecast timeline
1.2. Market Definitions
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. GVR’s Internal Database
1.5. Details of primary research
1.5.1. Data for primary interviews in North America
1.5.2. Data for primary interviews in Europe
1.5.3. Data for primary interviews in Asia Pacific
1.5.4. Data for primary interviews in Latin America
1.5.5. Data for Primary interviews in MEA
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.1.1. Approach 1: Commodity flow approach
1.7.2. Volume price analysis (Model 2)
1.7.2.1. Approach 2: Volume price analysis
1.8. Research Scope and Assumptions
1.8.1. List of Secondary Sources
1.8.2. List of Primary Sources
1.8.3. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Durable Medical Equipment Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Drivers Analysis
3.2.1.1. Growth in Chronic Diseases
3.2.1.2. Shift from Hospital-Based Care to Home-Based Care
3.2.1.3. Growing geriatric population
3.2.2. Market Restraints Analysis
3.2.2.1. High Equipment Costs
3.2.2.2. Limited Reimbursement
3.2.3. Market Opportunity Analysis
3.2.3.1. Post-Surgery & Rehabilitation Care
3.2.3.2. Technological Advancement and Product Innovation
3.2.3.3. Smart, Connected, and Data-Enabled Equipment
3.2.3.4. Emerging Market Expansion
3.2.4. Market Challenge Analysis
3.2.4.1. Skilled Workforce Shortage
3.3. Durable Medical Equipment Market Analysis Tools
3.3.1. Porter’s Analysis
3.3.1.1. Bargaining power of the suppliers
3.3.1.2. Bargaining power of the buyers
3.3.1.3. Threats of substitution
3.3.1.4. Threats from new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic and Social landscape
3.3.2.3. Technological landscape
3.3.2.4. Environmental landscape
3.3.2.5. Legal landscape
Chapter 4. Durable Medical Equipment Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Global Durable Medical Equipment Market: Product Movement Analysis, 2025 & 2033 (USD Million)
4.3. Global Durable Medical Equipment Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
4.4. Personal Mobility Devices
4.4.1. Personal mobility devices market revenue estimates and forecasts, 2021 – 2033 (USD Million)
4.4.2. Wheelchairs
4.4.2.1. Wheelchairs market revenue estimates and forecasts, 2021 – 2033 (USD Million)
4.4.3. Scooters
4.4.3.1. Scooters market revenue estimates and forecasts, 2021 – 2033 (USD Million)
4.4.4. Walker and rollators
4.4.4.1. Walker and rollators market revenue estimates and forecasts, 2021 – 2033 (USD Million)
4.4.5. Canes and crutches
4.4.5.1. Canes and crutches market revenue estimates and forecasts, 2021 – 2033 (USD Million)
4.4.6. Door Openers
4.4.6.1. Door openers market revenue estimates and forecasts, 2021 – 2033 (USD Million)
4.4.7. Other Devices
4.4.7.1. Other devices market revenue estimates and forecasts, 2021 – 2033 (USD Million)
4.5. Bathroom Safety Devices and Medical Furniture
4.5.1. Bathroom safety devices and medical furniture market revenue estimates and forecasts, 2021 – 2033 (USD Million)
4.5.2. Commodes and toilets
4.6.2.1. Commodes and toilets market revenue estimates and forecasts, 2021 – 2033 (USD Million)
4.5.3. Mattress & bedding devices
4.6.3.1. Mattress & bedding devices market revenue estimates and forecasts, 2021 – 2033 (USD Million)
4.6. Monitoring and Therapeutic Devices
4.6.1. Monitoring and therapeutic devices market revenue estimates and forecasts, 2021 – 2033 (USD Million)
4.6.2. Blood sugar monitors
4.6.2.1. Blood sugar monitors market revenue estimates and forecasts, 2021 – 2033 (USD Million)
4.6.3. Continuous Passive Motion (CPM)
4.6.3.1. Continuous Passive Motion (CPM) market revenue estimates and forecasts, 2021 – 2033 (USD Million)
4.6.4. Infusion pumps
4.6.4.1. Infusion pumps market revenue estimates and forecasts, 2021 – 2033 (USD Million)
4.6.5. Nebulizers
4.6.5.1. Nebulizers market revenue estimates and forecasts, 2021 – 2033 (USD Million)
4.6.6. Oxygen equipment
4.6.6.1. Oxygen equipment market revenue estimates and forecasts, 2021 – 2033 (USD Million)
4.6.7. Continuous positive airway pressure (CPAP)
4.6.7.1. Continuous positive airway pressure (CPAP) market revenue estimates and forecasts, 2021 – 2033 (USD Million)
4.6.8. Suction pumps
4.6.8.1. Suction pumps market revenue estimates and forecasts, 2021 – 2033 (USD Million)
4.6.9. Traction equipment
4.6.9.1. Traction equipment market revenue estimates and forecasts, 2021 – 2033 (USD Million)
4.6.10. Others equipment
4.6.10.1. Others equipment market revenue estimates and forecasts, 2021 – 2033 (USD Million)
Chapter 5. Durable Medical Equipment Market: End Use Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Global Durable Medical Equipment Market: End use, Movement Analysis, 2025 & 2033 (USD Million)
5.3. Global Durable Medical Equipment Market Size & Trend Analysis, by End use, 2021 to 2033 (USD Million)
5.4. Hospitals
5.4.1. Hospitals market revenue estimates and forecasts, 2021 – 2033 (USD Million)
5.5. Nursing Homes
5.5.1. Nursing homes market revenue estimates and forecasts, 2021 – 2033 (USD Million)
5.6. Home Healthcare
5.6.1. Home healthcare market revenue estimates and forecasts, 2021 – 2033 (USD Million)
5.7. Other end-user
5.7.1. Other end-user market revenue estimates and forecasts, 2021 – 2033 (USD Million)
Chapter 6. Durable Medical Equipment Market: Regional Estimates & Trend Analysis by Product, and End Use
6.1. Regional Dashboard
6.2. Market Size and Trend Analysis, 2021 to 2033
6.3. North America
6.3.1. North America durable medical equipment market estimates and forecasts, 2021 – 2033 (USD Million)
6.3.2. U.S.
6.3.2.1. Key country dynamics
6.3.2.2. Competitive scenario
6.3.2.3. Regulatory framework
6.3.2.4. Reimbursement scenario
6.3.2.5. U.S. durable medical equipment market estimates and forecasts, 2021 – 2033 (USD Million)
6.3.3. Canada
6.3.3.1. Key country dynamics
6.3.3.2. Competitive scenario
6.3.3.3. Regulatory framework
6.3.3.4. Reimbursement scenario
6.3.3.5. Canada durable medical equipment market estimates and forecasts, 2021 – 2033 (USD Million)
6.3.4. Mexico
6.3.4.1. Key country dynamics
6.3.4.2. Competitive scenario
6.3.4.3. Regulatory framework
6.3.4.4. Reimbursement scenario
6.3.4.5. Mexico durable medical equipment market estimates and forecasts, 2021 – 2033 (USD Million)
6.4. Europe
6.4.1. Europe durable medical equipment market estimates and forecasts, 2021 – 2033 (USD Million)
6.4.2. UK
6.4.2.1. Key country dynamics
6.4.2.2. Competitive scenario
6.4.2.3. Regulatory framework
6.4.2.4. Reimbursement scenario
6.4.2.5. UK durable medical equipment market estimates and forecasts, 2021 – 2033 (USD Million)
6.4.3. Germany
6.4.3.1. Key country dynamics
6.4.3.2. Competitive scenario
6.4.3.3. Regulatory framework
6.4.3.4. Reimbursement scenario
6.4.3.5. Germany durable medical equipment market estimates and forecasts, 2021 – 2033 (USD Million)
6.4.4. France
6.4.4.1. Key country dynamics
6.4.4.2. Competitive scenario
6.4.4.3. Regulatory framework
6.4.4.4. Reimbursement scenario
6.4.4.5. France durable medical equipment market estimates and forecasts, 2021 – 2033 (USD Million)
6.4.5. Italy
6.4.5.1. Key country dynamics
6.4.5.2. Competitive scenario
6.4.5.3. Regulatory framework
6.4.5.4. Reimbursement scenario
6.4.5.5. Italy durable medical equipment market estimates and forecasts, 2021 – 2033 (USD Million)
6.4.6. Spain
6.4.6.1. Key country dynamics
6.4.6.2. Competitive scenario
6.4.6.3. Regulatory framework
6.4.6.4. Reimbursement scenario
6.4.6.5. Spain durable medical equipment market estimates and forecasts, 2021 – 2033 (USD Million)
6.4.7. Sweden
6.4.7.1. Key country dynamics
6.4.7.2. Competitive scenario
6.4.7.3. Regulatory framework
6.4.7.4. Reimbursement scenario
6.4.7.5. Sweden durable medical equipment market estimates and forecasts, 2021 – 2033 (USD Million)
6.4.8. Denmark
6.4.8.1. Key country dynamics
6.4.8.2. Competitive scenario
6.4.8.3. Regulatory framework
6.4.8.4. Reimbursement scenario
6.4.8.5. Denmark durable medical equipment market estimates and forecasts, 2021 – 2033 (USD Million)
6.4.9. Norway
6.4.9.1. Key country dynamics
6.4.9.2. Competitive scenario
6.4.9.3. Regulatory framework
6.4.9.4. Reimbursement scenario
6.4.9.5. Norway durable medical equipment market estimates and forecasts, 2021 – 2033 (USD Million)
6.5. Asia Pacific
6.5.1. Asia Pacific durable medical equipment market estimates and forecasts, 2021 – 2033 (USD Million)
6.5.2. China
6.5.2.1. Key country dynamics
6.5.2.2. Competitive scenario
6.5.2.3. Regulatory framework
6.5.2.4. Reimbursement scenario
6.5.2.5. China durable medical equipment market estimates and forecasts, 2021 – 2033 (USD Million)
6.5.3. Japan
6.5.3.1. Key country dynamics
6.5.3.2. Competitive scenario
6.5.3.3. Regulatory framework
6.5.3.4. Reimbursement scenario
6.5.3.5. Japan durable medical equipment market estimates and forecasts, 2021 – 2033 (USD Million)
6.5.4. India
6.5.4.1. Key country dynamics
6.5.4.2. Competitive scenario
6.5.4.3. Regulatory framework
6.5.4.4. Reimbursement scenario
6.5.4.5. India durable medical equipment market estimates and forecasts, 2021 – 2033 (USD Million)
6.5.5. South Korea
6.5.5.1. Key country dynamics
6.5.5.2. Competitive scenario
6.5.5.3. Regulatory framework
6.5.5.4. Reimbursement scenario
6.5.5.5. South Korea durable medical equipment market estimates and forecasts, 2021 – 2033 (USD Million)
6.5.6. Australia
6.5.6.1. Key country dynamics
6.5.6.2. Competitive scenario
6.5.6.3. Regulatory framework
6.5.6.4. Reimbursement scenario
6.5.6.5. Australia durable medical equipment market estimates and forecasts, 2021 – 2033 (USD Million)
6.5.7. Thailand
6.5.7.1. Key country dynamics
6.5.7.2. Competitive scenario
6.5.7.3. Regulatory framework
6.5.7.4. Reimbursement scenario
6.5.7.5. Thailand durable medical equipment market estimates and forecasts, 2021 – 2033 (USD Million)
6.6. Latin America
6.6.1. Latin America durable medical equipment market estimates and forecasts, 2021 – 2033 (USD Million)
6.6.2. Brazil
6.6.2.1. Key country dynamics
6.6.2.2. Competitive scenario
6.6.2.3. Regulatory framework
6.6.2.4. Reimbursement scenario
6.6.2.5. Brazil durable medical equipment market estimates and forecasts, 2021 – 2033 (USD Million)
6.6.3. Argentina
6.6.3.1. Key country dynamics
6.6.3.2. Competitive scenario
6.6.3.3. Regulatory framework
6.6.3.4. Reimbursement scenario
6.6.3.5. Argentina durable medical equipment market estimates and forecasts, 2021 – 2033 (USD Million)
6.7. Middle East and Africa
6.7.1. Middle East and Africa durable medical equipment market estimates and forecasts, 2021 – 2033 (USD Million)
6.7.2. South Africa
6.7.2.1. Key country dynamics
6.7.2.2. Competitive scenario
6.7.2.3. Regulatory framework
6.7.2.4. Reimbursement scenario
6.7.2.5. South Africa durable medical equipment market estimates and forecasts, 2021 – 2033 (USD Million)
6.7.3. Saudi Arabia
6.7.3.1. Key country dynamics
6.7.3.2. Competitive scenario
6.7.3.3. Regulatory framework
6.7.3.4. Reimbursement scenario
6.7.3.5. Saudi Arabia durable medical equipment market estimates and forecasts, 2021 – 2033 (USD Million)
6.7.4. UAE
6.7.4.1. Key country dynamics
6.7.4.2. Competitive scenario
6.7.4.3. Regulatory framework
6.7.4.4. Reimbursement scenario
6.7.4.5. UAE durable medical equipment market estimates and forecasts, 2021 – 2033 (USD Million)
6.7.5. Kuwait
6.7.5.1. Key country dynamics
6.7.5.2. Competitive scenario
6.7.5.3. Regulatory framework
6.7.5.4. Reimbursement scenario
6.7.5.5. Kuwait durable medical equipment market estimates and forecasts, 2021 – 2033 (USD Million)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis by Key Market Participants
7.2. Company Categorization
7.3. Company Market Share Analysis, 2025
7.4. Company Heat Map Analysis
7.5. Strategy Mapping
7.5.1. Expansion
7.5.2. Mergers & Acquisition
7.5.3. Partnerships & Collaborations
7.5.4. New Product Launches
7.5.5. Research And Development
7.5.6. Company Profiles
7.5.7. Invacare Corporation
7.5.7.1. Company overview
7.5.7.2. Financial performance
7.5.7.3. Product Benchmarking
7.5.7.4. Strategic initiatives
7.5.8. Arjo
7.5.8.1. Company overview
7.5.8.2. Financial performance
7.5.8.3. Product Benchmarking
7.5.8.4. Strategic initiatives
7.5.9. Stryker Corporation
7.5.9.1. Company overview
7.5.9.2. Financial performance
7.5.9.3. Product Benchmarking
7.5.9.4. Strategic initiatives
7.5.10. Hill Rom, Inc.
7.5.10.1. Company overview
7.5.10.2. Financial performance
7.5.10.3. Product Benchmarking
7.5.10.4. Strategic initiatives
7.5.11. Drive Medical
7.5.11.1. Company overview
7.5.11.2. Financial performance
7.5.11.3. Product Benchmarking
7.5.11.4. Strategic initiatives
7.5.12. GF Health Products, Inc.
7.5.12.1. Company overview
7.5.12.2. Financial performance
7.5.12.3. Product Benchmarking
7.5.12.4. Strategic initiatives
7.5.13. Sunrise Medical
7.5.13.1. Company overview
7.5.13.2. Financial performance
7.5.13.3. Product Benchmarking
7.5.13.4. Strategic initiatives
7.5.14. Medline Industries
7.5.14.1. Company overview
7.5.14.2. Financial performance
7.5.14.3. Product Benchmarking
7.5.14.4. Strategic initiatives
7.5.15. Carex Health Brands, Inc
7.5.15.1. Company overview
7.5.15.2. Financial performance
7.5.15.3. Product Benchmarking
7.5.15.4. Strategic initiatives
7.5.16. BD
7.5.16.1. Company overview
7.5.16.2. Financial performance
7.5.16.3. Product Benchmarking
7.5.16.4. Strategic initiatives
7.5.17. GE HealthCare
7.5.17.1. Company overview
7.5.17.2. Financial performance
7.5.17.3. Product Benchmarking
7.5.17.4. Strategic initiatives
7.5.18. Medtronic
7.5.18.1. Company overview
7.5.18.2. Financial performance
7.5.18.3. Product Benchmarking
7.5.18.4. Strategic initiatives
7.5.19. Compass Health Brands
7.5.19.1. Company overview
7.5.19.2. Financial performance
7.5.19.3. Product Benchmarking
7.5.19.4. Strategic initiatives
7.5.20. Getinge AB
7.5.20.1. Company overview
7.5.20.2. Financial performance
7.5.20.3. Product Benchmarking
7.5.20.4. Strategic initiatives
7.5.21. Resmed Inc.
7.5.21.1. Company overview
7.5.21.2. Financial performance
7.5.21.3. Product Benchmarking
7.5.21.4. Strategic initiatives
7.5.22. Cardinal Health
7.5.22.1. Company overview
7.5.22.2. Financial performance
7.5.22.3. Product Benchmarking
7.5.22.4. Strategic initiatives
7.5.23. Drive DeVilbiss Healthcare
7.5.23.1. Company overview
7.5.23.2. Financial performance
7.5.23.3. Product Benchmarking
7.5.23.4. Strategic initiatives
7.5.24. NOVA Medical Products
7.5.24.1. Company overview
7.5.24.2. Financial performance
7.5.24.3. Product Benchmarking
7.5.24.4. Strategic initiatives
7.5.25. Kaye Products, Inc.
7.5.25.1. Company overview
7.5.25.2. Financial performance
7.5.25.3. Product Benchmarking
7.5.25.4. Strategic initiatives
7.5.26. Karman Healthcare, Inc.
7.5.26.1. Company overview
7.5.26.2. Financial performance
7.5.26.3. Product Benchmarking
7.5.26.4. Strategic initiatives
7.5.27. Numotion
7.5.27.1. Company overview
7.5.27.2. Financial performance
7.5.27.3. Product Benchmarking
7.5.27.4. Strategic initiatives
7.5.28. Pride Mobility Products Corporation
7.5.28.1. Company overview
7.5.28.2. Financial performance
7.5.28.3. Product Benchmarking
7.5.28.4. Strategic initiatives
7.5.29. Inogen, Inc.
7.5.29.1. Company overview
7.5.29.2. Financial performance
7.5.29.3. Product Benchmarking
7.5.29.4. Strategic initiatives
7.5.30. CAIRE, Inc. (Niterra Group)
7.5.30.1. Company overview
7.5.30.2. Financial performance
7.5.30.3. Product Benchmarking
7.5.30.4. Strategic initiatives
7.5.31. Portable Oxygen Solutions
7.5.31.1. Company overview
7.5.31.2. Financial performance
7.5.31.3. Product Benchmarking
7.5.31.4. Strategic initiatives
7.5.32. Rhythm Healthcare, LLC
7.5.32.1. Company overview
7.5.32.2. Financial performance
7.5.32.3. Product Benchmarking
7.5.32.4. Strategic initiatives
7.5.33. MedaCure Inc.
7.5.33.1. Company overview
7.5.33.2. Financial performance
7.5.33.3. Product Benchmarking
7.5.33.4. Strategic initiatives
7.5.34. Thermo Fisher Scientific, Inc.
7.5.34.1. Company overview
7.5.34.2. Financial performance
7.5.34.3. Product Benchmarking
7.5.34.4. Strategic initiatives
7.5.35. Abbott
7.5.35.1. Company overview
7.5.35.2. Financial performance
7.5.35.3. Product Benchmarking
7.5.35.4. Strategic initiatives
7.5.36. F. Hoffmann-La Roche Ltd.
7.5.36.1. Company overview
7.5.36.2. Financial performance
7.5.36.3. Product Benchmarking
7.5.36.4. Strategic initiatives
7.5.37. Biotronic
7.5.37.1. Company overview
7.5.37.2. Financial performance
7.5.37.3. Product Benchmarking
7.5.37.4. Strategic initiatives
7.5.38. Ascensia Diabetes Care Holdings AG
7.5.38.1. Company overview
7.5.38.2. Financial performance
7.5.38.3. Product Benchmarking
7.5.38.4. Strategic initiatives
7.5.39. Byram Healthcare Centers, Inc. (Owens & Minor)
7.5.39.1. Company overview
7.5.39.2. Financial performance
7.5.39.3. Product Benchmarking
7.5.39.4. Strategic initiatives
7.5.40. Novo Nordisk
7.5.40.1. Company overview
7.5.40.2. Financial performance
7.5.40.3. Product Benchmarking
7.5.40.4. Strategic initiatives
7.5.41. Insulet Corporation
7.5.41.1. Company overview
7.5.41.2. Financial performance
7.5.41.3. Product Benchmarking
7.5.41.4. Strategic initiatives
7.5.42. Baxter
7.5.42.1. Company overview
7.5.42.2. Financial performance
7.5.42.3. Product Benchmarking
7.5.42.4. Strategic initiatives
7.5.43. B. Braun SE
7.5.43.1. Company overview
7.5.43.2. Financial performance
7.5.43.3. Product Benchmarking
7.5.43.4. Strategic initiatives
7.5.44. Micrel Medical Devices SA
7.5.44.1. Company overview
7.5.44.2. Financial performance
7.5.44.3. Product Benchmarking
7.5.44.4. Strategic initiatives
7.5.45. Boston Scientific Corporation
7.5.45.1. Company overview
7.5.45.2. Financial performance
7.5.45.3. Product Benchmarking
7.5.45.4. Strategic initiatives
7.5.46. Tandem Diabetes Care, Inc.
7.5.46.1. Company overview
7.5.46.2. Financial performance
7.5.46.3. Product Benchmarking
7.5.46.4. Strategic initiatives
7.5.47. Moog, Inc.
7.5.47.1. Company overview
7.5.47.2. Financial performance
7.5.47.3. Product Benchmarking
7.5.47.4. Strategic initiatives
7.5.48. IRadimed Corporation
7.5.48.1. Company overview
7.5.48.2. Financial performance
7.5.48.3. Product Benchmarking
7.5.48.4. Strategic initiatives
7.5.49. Koninklijke Philips N.V.
7.5.49.1. Company overview
7.5.49.2. Financial performance
7.5.49.3. Product Benchmarking
7.5.49.4. Strategic initiatives
7.5.50. Siemens Medical Solutions USA, Inc.
7.5.50.1. Company overview
7.5.50.2. Financial performance
7.5.50.3. Product Benchmarking
7.5.50.4. Strategic initiatives
7.5.51. Essity
7.5.51.1. Company overview
7.5.51.2. Financial performance
7.5.51.3. Product Benchmarking
7.5.51.4. Strategic initiatives
7.5.52. Coloplast Corporation
7.5.52.1. Company overview
7.5.52.2. Financial performance
7.5.52.3. Product Benchmarking
7.5.52.4. Strategic initiatives
7.5.53. Paul Hartmann AG
7.5.53.1. Company overview
7.5.53.2. Financial performance
7.5.53.3. Product Benchmarking
7.5.53.4. Strategic initiatives
7.5.54. Hollister Incorporated
7.5.54.1. Company overview
7.5.54.2. Financial performance
7.5.54.3. Product Benchmarking
7.5.54.4. Strategic initiatives
7.5.55. Convatec Group PLC
7.5.55.1. Company overview
7.5.55.2. Financial performance
7.5.55.3. Product Benchmarking
7.5.55.4. Strategic initiatives
7.5.56. Enovis Corporation
7.5.56.1. Company overview
7.5.56.2. Financial performance
7.5.56.3. Product Benchmarking
7.5.56.4. Strategic initiatives
7.5.57. Zynex, Inc.
7.5.57.1. Company overview
7.5.57.2. Financial performance
7.5.57.3. Product Benchmarking
7.5.57.4. Strategic initiatives
7.5.58. ZOLL Medical Corporation (Asahi Kasei Corporation)
7.5.58.1. Company overview
7.5.58.2. Financial performance
7.5.58.3. Product Benchmarking
7.5.58.4. Strategic initiatives
7.5.59. Össur (Embla Medical)
7.5.59.1. Company overview
7.5.59.2. Financial performance
7.5.59.3. Product Benchmarking
7.5.59.4. Strategic initiatives
7.5.60. Breg, Inc.
7.5.60.1. Company overview
7.5.60.2. Financial performance
7.5.60.3. Product Benchmarking
7.5.60.4. Strategic initiatives
7.5.61. Bauerfeind USA, Inc.
7.5.61.1. Company overview
7.5.61.2. Financial performance
7.5.61.3. Product Benchmarking
7.5.61.4. Strategic initiatives

List of Tables

Table 1 List of Abbreviation
Table 2 North America durable medical equipment market, by region, 2021 – 2033 (USD Million)
Table 3 North America durable medical equipment market, by product, 2021 – 2033 (USD Million)
Table 4 North America durable medical equipment market, by end use, 2021 – 2033 (USD Million)
Table 5 U.S. durable medical equipment market, by product, 2021 – 2033 (USD Million)
Table 6 U.S. durable medical equipment market, by end use, 2021 – 2033 (USD Million)
Table 7 Canada durable medical equipment market, by product, 2021 – 2033 (USD Million)
Table 8 Canada durable medical equipment market, by end use, 2021 – 2033 (USD Million)
Table 9 Mexico durable medical equipment market, by product, 2021 – 2033 (USD Million)
Table 10 Mexico durable medical equipment market, by end use, 2021 – 2033 (USD Million)
Table 11 Europe durable medical equipment market, by region, 2021 – 2033 (USD Million)
Table 12 Europe durable medical equipment market, by product, 2021 – 2033 (USD Million)
Table 13 Europe durable medical equipment market, by end use, 2021 – 2033 (USD Million)
Table 14 Germany durable medical equipment market, by product, 2021 – 2033 (USD Million)
Table 15 Germany durable medical equipment market, by end use, 2021 – 2033 (USD Million)
Table 16 UK durable medical equipment market, by product, 2021 – 2033 (USD Million)
Table 17 UK durable medical equipment market, by end use, 2021 – 2033 (USD Million)
Table 18 France durable medical equipment market, by product, 2021 – 2033 (USD Million)
Table 19 France durable medical equipment market, by end use, 2021 – 2033 (USD Million)
Table 20 Italy durable medical equipment market, by product, 2021 – 2033 (USD Million)
Table 21 Italy durable medical equipment market, by end use, 2021 – 2033 (USD Million)
Table 22 Spain durable medical equipment market, by product, 2021 – 2033 (USD Million)
Table 23 Spain durable medical equipment market, by end use, 2021 – 2033 (USD Million)
Table 24 Denmark durable medical equipment market, by product, 2021 – 2033 (USD Million)
Table 25 Denmark durable medical equipment market, by end use, 2021 – 2033 (USD Million)
Table 26 Sweden durable medical equipment market, by product, 2021 – 2033 (USD Million)
Table 27 Sweden durable medical equipment market, by end use, 2021 – 2033 (USD Million)
Table 28 Norway durable medical equipment market, by product, 2021 – 2033 (USD Million)
Table 29 Norway durable medical equipment market, by end use, 2021 – 2033 (USD Million)
Table 30 Asia Pacific durable medical equipment market, by region, 2021 – 2033 (USD Million)
Table 31 Asia Pacific durable medical equipment market, by product, 2021 – 2033 (USD Million)
Table 32 Asia Pacific durable medical equipment market, by end use, 2021 – 2033 (USD Million)
Table 33 China durable medical equipment market, by product, 2021 – 2033 (USD Million)
Table 34 China durable medical equipment market, by end use, 2021 – 2033 (USD Million)
Table 35 Japan durable medical equipment market, by product, 2021 – 2033 (USD Million)
Table 36 Japan durable medical equipment market, by end use, 2021 – 2033 (USD Million)
Table 37 India durable medical equipment market, by product, 2021 – 2033 (USD Million)
Table 38 India durable medical equipment market, by end use, 2021 – 2033 (USD Million)
Table 39 South Korea durable medical equipment market, by product, 2021 – 2033 (USD Million)
Table 40 South Korea durable medical equipment market, by end use, 2021 – 2033 (USD Million)
Table 41 Australia durable medical equipment market, by product, 2021 – 2033 (USD Million)
Table 42 Australia durable medical equipment market, by end use, 2021 – 2033 (USD Million)
Table 43 Thailand durable medical equipment market, by product, 2021 – 2033 (USD Million)
Table 44 Thailand durable medical equipment market, by product, 2021 – 2033 (USD Million)
Table 45 Latin America durable medical equipment market, by region, 2021 – 2033 (USD Million)
Table 46 Latin America durable medical equipment market, by product, 2021 – 2033 (USD Million)
Table 47 Latin America durable medical equipment market, by end use, 2021 – 2033 (USD Million)
Table 48 Brazil durable medical equipment market, by product, 2021 – 2033 (USD Million)
Table 49 Brazil durable medical equipment market, by end use, 2021 – 2033 (USD Million)
Table 50 Argentina durable medical equipment market, by product, 2021 – 2033 (USD Million)
Table 51 Argentina durable medical equipment market, by end use, 2021 – 2033 (USD Million)
Table 52 MEA durable medical equipment market, by region, 2021 – 2033 (USD Million)
Table 53 MEA durable medical equipment market, by product, 2021 – 2033 (USD Million)
Table 54 MEA durable medical equipment market, by end use, 2021 – 2033 (USD Million)
Table 55 South Africa durable medical equipment market, by product, 2021 – 2033 (USD Million)
Table 56 South Africa durable medical equipment market, by end use, 2021 – 2033 (USD Million)
Table 57 Saudi Arabia durable medical equipment market, by product, 2021 – 2033 (USD Million)
Table 58 Saudi Arabia durable medical equipment market, by end use, 2021 – 2033 (USD Million)
Table 59 UAE durable medical equipment market, by product, 2021 – 2033 (USD Million)
Table 60 UAE durable medical equipment market, by end use, 2021 – 2033 (USD Million)
Table 61 Kuwait durable medical equipment market, by product, 2021 – 2033 (USD Million)
Table 62 Kuwait durable medical equipment market, by end use, 2021 – 2033 (USD Million)

List of Figures

Fig. 1 Durable medical equipment market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Data analysis models
Fig. 5 Market formulation and validation
Fig. 6 Data validating & publishing
Fig. 7 Market snapshot
Fig. 8 Segment snapshot
Fig. 9 Competitive landscape snapshot
Fig. 10 Durable medical equipment – market size and growth prospects (USD million)
Fig. 11 Durable medical equipment market: Industry Value Chain Analysis
Fig. 12 Durable medical equipment market: Market Dynamics
Fig. 13 Durable medical equipment market: PORTER’s Analysis
Fig. 14 Durable medical equipment market: PESTEL Analysis
Fig. 15 Durable medical equipment market share by product, 2025 & 2033 (USD Million)
Fig. 16 Durable medical equipment market, by product: market share, 2023 & 2030
Fig. 17 Personal mobility devices market estimates & forecasts, 2021 – 2033 (Revenue, USD Million)
Fig. 18 Wheelchairs market estimates & forecasts, 2021 – 2033 (Revenue, USD Million)
Fig. 19 Scooters market estimates & forecasts, 2021 – 2033 (Revenue, USD Million)
Fig. 20 Walker and rollators market estimates & forecasts, 2021 – 2033 (Revenue, USD Million)
Fig. 21 Canes and crutches market estimates & forecasts, 2021 – 2033 (Revenue, USD Million)
Fig. 22 Door openers market estimates & forecasts, 2021 – 2033 (Revenue, USD Million)
Fig. 23 Other devices market share by product, 2025 & 2033 (USD Million)
Fig. 24 Bathroom safety devices and medical furniture market share by product, 2025 & 2033 (USD Million)
Fig. 25 Commodes and toilets market share by product, 2025 & 2033 (USD Million)
Fig. 26 Mattress & bedding devices market share by product, 2025 & 2033 (USD Million)
Fig. 27 Monitoring and therapeutic devices market share by product, 2025 & 2033 (USD Million)
Fig. 28 Blood sugar monitors market share by product, 2025 & 2033 (USD Million)
Fig. 29 Continuous passive motion (CPM) market share by product, 2025 & 2033 (USD Million)
Fig. 30 Infusion pumps market share by product, 2025 & 2033 (USD Million)
Fig. 31 Nebulizers market share by product, 2025 & 2033 (USD Million)
Fig. 32 Oxygen equipment market share by product, 2025 & 2033 (USD Million)
Fig. 33 Continuous positive airway pressure (CPAP) market share by product, 2025 & 2033 (USD Million)
Fig. 34 Suction pumps market share by product, 2025 & 2033 (USD Million)
Fig. 35 Traction equipment market share by product, 2025 & 2033 (USD Million)
Fig. 36 Others equipment market share by product, 2025 & 2033 (USD Million)
Fig. 37 Durable medical equipment market share by end use, 2025 & 2033 (USD Million)
Fig. 38 Durable medical equipment market, by end use: market share, 2023 & 2030
Fig. 39 Hospitals market estimates & forecasts, 2021 – 2033 (Revenue, USD Million)
Fig. 40 Nursing homes market estimates & forecasts, 2021 – 2033 (Revenue, USD Million)
Fig. 41 Home healthcare market estimates & forecasts, 2021 – 2033 (Revenue, USD Million)
Fig. 42 Other End-user market estimates & forecasts, 2021 – 2033 (Revenue, USD Million)
Fig. 43 Regional marketplace: key takeaways
Fig. 44 North America durable medical equipment market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 45 US durable medical equipment market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 46 Canada durable medical equipment market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 47 Mexico durable medical equipment market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 48 Europe durable medical equipment market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 49 UK durable medical equipment market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 50 Germany durable medical equipment market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 51 France durable medical equipment market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 52 Italy durable medical equipment market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 53 Spain durable medical equipment market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 54 Sweden durable medical equipment market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 55 Denmark durable medical equipment market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 56 Norway durable medical equipment market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 57 Asia Pacific durable medical equipment market estimates and forecast, 2021 – 2033 (USD Million)
Fig. 58 China durable medical equipment market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 59 Japan durable medical equipment market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 60 India durable medical equipment market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 61 South Korea durable medical equipment market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 62 Australia durable medical equipment market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 63 Thailand durable medical equipment market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 64 Latin America durable medical equipment market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 65 Brazil durable medical equipment market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 66 Argentina durable medical equipment market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 67 MEA durable medical equipment market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 68 South Africa durable medical equipment market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 69 Saudi Arabia durable medical equipment market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 70 UAE durable medical equipment market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 71 Kuwait durable medical equipment market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 72 Key company categorization
Fig. 73 Company market positioning
Fig. 74 Key company market share analysis, 2025
Fig. 75 Strategic framework

---

---